Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ENTAENANTA PHARMACEUTICALS INC

Nasdaq · CIK 0001177648
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end0930
XBRL facts369

Identity from submissions API

NameENANTA PHARMACEUTICALS INC
CIK0001177648
TickersENTA
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN043205099
LEI—
Fiscal year end0930
State of incorporation—
Phone617 607 0800
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
4 KINGSBURY AVENUE
WATERTOWN
MA
02472
MA
Mailing address
4 KINGSBURY AVENUE
WATERTOWN
MA
02472
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

839 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-18 10-K 10-K 0001193125-26-466170 001-35839 261568002 34 29685614 1 1
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-128729 005-87373 261563806 34 14836
2026-11-16 8-K 8-K 2.02,9.01 0001193125-26-463508 001-35839 261560848 34 490179 1 1
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000908834-26-000532 005-87373 261555820 34 27916
2026-10-29 8-K 8-K 8.01 0001193125-26-437774 001-35839 261501672 34 146417 1 1
2026-10-28 8-K 8-K 5.02,7.01,9.01 0001193125-26-435092 001-35839 261492423 34 160695 1 1
2026-10-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002052113-26-001073 005-87373 261490496 34 10851
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003479 005-87373 261276367 34 11346
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000908834-26-000416 005-87373 261276325 34 45238
2026-08-12 10-Q 10-Q 0001193125-26-345719 001-35839 261265271 34 11783375 1 1
2026-08-10 8-K 8-K 2.02,9.01 0001193125-26-342336 001-35839 261258344 34 465765 1 1
2026-08-10 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-26-000266 4845
2026-07-02 8-K 8-K 1.01,9.01 0001193125-26-294837 001-35839 261152573 34 426648 1 1
2026-07-02 424B5 424B5 0001193125-26-294828 333-293390 261152530 33 601710
2026-06-23 8-K 8-K 8.01 0001193125-26-279803 001-35839 261112327 34 132387 1 1
2026-06-18 8-K 8-K 7.01,9.01 0001193125-26-274950 001-35839 261100400 34 11832718 1 1
2026-05-13 S-8 S-8 0001193125-26-220600 333-295821 26970920 33 182854 1 1
2026-05-13 10-Q 10-Q 0001193125-26-220572 001-35839 26970867 34 10469165 1 1
2026-05-11 8-K 8-K 2.02,9.01 0001193125-26-216735 001-35839 26963120 34 470948 1 1
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-001192 005-87373 26799963 34 7054
2026-03-26 8-K 8-K 8.01 0001193125-26-125113 001-35839 26794382 34 145114 1 1
2026-03-13 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-26-000143 5318
2026-03-13 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-26-000142 5270
2026-03-13 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-26-000141 5335
2026-03-13 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-26-000140 5308
2026-03-13 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-26-000139 5302
2026-03-13 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-26-000138 5318
2026-03-12 8-K 8-K 5.02,5.07,9.01 0001193125-26-104109 001-35839 26747620 34 370217 1 1
2026-02-20 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000642 333-293390 26661947 33 1682
2026-02-17 CORRESP filename1.htm 0001193125-26-055328 143792
2026-02-17 UPLOAD filename1.pdf 0000000000-26-001607 333-293390 40034
2026-02-13 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-26-000016 8462
2026-02-13 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-26-000014 8518
2026-02-13 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-26-000012 8538
2026-02-13 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-26-000010 8535
2026-02-13 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-26-000008 8521
2026-02-13 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-26-000006 8517
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-000711 005-87373 26629092 34 11192
2026-02-11 S-3 S-3 0001193125-26-046712 333-293390 26621529 33 619101 1 1
2026-02-11 10-Q 10-Q 0001193125-26-046502 001-35839 26620600 34 9551430 1 1
2026-02-09 8-K 8-K 2.02,9.01 0001193125-26-042812 001-35839 26611606 34 407191 1 1
2026-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000908834-26-000042 005-87373 26602418 34 58130
2026-01-26 ARS ARS 0001193125-26-022589 001-35839 26560629 34 12065252
2026-01-26 DEFA14A DEFA14A 0001193125-26-022585 001-35839 26560613 34 116553
2026-01-26 DEF 14A DEF 14A 0001193125-26-022558 001-35839 26560533 34 3501635 1 1
2026-01-20 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-005096 005-87373 26543494 34 18767
2025-12-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-25-000070 5583
2025-12-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-25-000067 5564
2025-12-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-25-000065 5477
2025-12-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-25-000063 5461
2025-12-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-25-000061 5481
2025-12-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-25-000059 5462
2025-12-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-25-000057 5457
2025-12-05 144 xsl144X01/primary_doc.xml 0001571211-25-000003 001-35839 251554206 33 4417
2025-12-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-25-000053 6646
2025-12-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-25-000050 6629
2025-12-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-25-000048 4693
2025-12-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-25-000046 4713
2025-12-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-25-000044 4694
2025-12-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-25-000042 4690
2025-11-26 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-25-000038 7462
2025-11-26 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-25-000036 7446
2025-11-26 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-25-000034 5438
2025-11-26 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-25-000032 5461
2025-11-26 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-25-000030 5390
2025-11-26 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-25-000028 5458
2025-11-26 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-25-000026 5441
2025-11-26 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0002064832-25-000024 5436
2025-11-19 10-K 10-K 0001193125-25-288121 001-35839 251499549 34 27289533 1 1
2025-11-17 8-K 8-K 2.02,9.01 0001193125-25-284633 001-35839 251491246 34 468204 1 1
2025-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-111375 005-87373 251479025 34 18202
2025-11-07 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000261 005-87373 251461436 34 10441
2025-10-09 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-004234 005-87373 251385662 34 11067
2025-10-01 8-K 8-K 8.01,9.01 0001193125-25-226828 001-35839 251365019 34 433221 1 1
2025-10-01 424B5 424B5 0001193125-25-226794 333-275723 251364882 33 583272
2025-09-30 424B5 424B5 0001193125-25-225149 333-275723 251361132 33 584867
2025-09-29 8-K 8-K 7.01,9.01 0001193125-25-221791 001-35839 251352357 34 3340311 1 1
2025-09-29 8-K 8-K 7.01,8.01,9.01 0001193125-25-221527 001-35839 251352053 34 198332 1 1
2025-09-08 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-015415 19562
2025-09-08 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-015414 16605
2025-08-27 8-K 8-K 5.02 0001193125-25-189691 001-35839 251265231 34 150591 1 1
2025-08-20 8-K 8-K 7.01,8.01,9.01 0001193125-25-183719 001-35839 251233841 34 222497 1 1
2025-08-13 10-Q 10-Q 0001193125-25-179795 001-35839 251211273 34 8788049 1 1
2025-08-11 8-K 8-K 2.02,9.01 0001193125-25-177941 001-35839 251202189 34 452603 1 1
2025-08-08 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-013981 4707
2025-05-14 S-8 S-8 0001193125-25-119902 333-287274 25946538 33 63477
2025-05-14 10-Q 10-Q 0000950170-25-071340 001-35839 25945063 34 10857017 1 1
2025-05-12 8-K 8-K 2.02,9.01 0000950170-25-069155 001-35839 25934686 34 466319 1 1
2025-04-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001576419-25-000590 005-87373 25844521 34 10789
2025-03-17 8-K 8-K 5.02,5.07,9.01 0000950170-25-040230 001-35839 25744371 34 384812 1 1
2025-03-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-005507 8619
2025-03-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-005506 8599
2025-03-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-005505 8645
2025-03-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-005504 8608
2025-03-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-005503 8625
2025-03-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-005502 8638
2025-02-14 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-25-021421 005-87373 25630665 34 10762
2025-02-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-002568 6519
2025-02-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-002563 6539
2025-02-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-002561 6536
2025-02-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-002558 6521
2025-02-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-002553 6533
2025-02-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-002549 6517
2025-02-12 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-002225 5592
2025-02-12 10-Q 10-Q 0000950170-25-018810 001-35839 25614664 34 10623758 1 1
2025-02-11 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000908834-25-000061 005-87373 25608518 34 52928
2025-02-10 8-K 8-K 2.02,9.01 0000950170-25-017035 001-35839 25605730 34 401685 1 1
2025-01-27 ARS ARS 0001193125-25-013335 001-35839 25559222 34 13072856
2025-01-27 DEFA14A DEFA14A 0001193125-25-013325 001-35839 25559186 34 635091
2025-01-27 DEF 14A DEF 14A 0000950170-25-009168 001-35839 25558796 34 15908034 1 1
2025-01-22 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-005234 005-87373 25545902 34 18197
2024-12-10 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-020386 5495
2024-12-10 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-020384 5475
2024-12-10 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-020382 5491
2024-12-10 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-020380 5476
2024-12-10 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-020378 5489
2024-12-10 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-020375 5471
2024-12-09 8-K 8-K 7.01,8.01,9.01 0001193125-24-272936 001-35839 241533929 34 3256629 1 1
2024-12-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-019990 4699
2024-12-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-019987 4719
2024-12-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-019982 4724
2024-12-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-019980 4737
2024-12-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-019974 4719
2024-11-27 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-019776 5396
2024-11-27 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-019774 8742
2024-11-27 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-019772 8788
2024-11-27 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-019770 5461
2024-11-27 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-019768 8753
2024-11-27 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-019766 8751
2024-11-27 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-019764 8735
2024-11-27 10-K 10-K 0000950170-24-131260 001-35839 241506461 34 33713602 1 1
2024-11-25 8-K 8-K 2.02,9.01 0000950170-24-130553 001-35839 241495908 34 453526 1 1
2024-11-14 SC 13G/A armistice-enta093024a2.htm 0001172661-24-005156 005-87373 241461651 34 90690
2024-10-17 SC 13G/A ENTA_SC13GA1.htm 0001273087-24-000102 005-87373 241377967 34 81485
2024-08-09 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-014792 9644
2024-08-07 10-Q 10-Q 0000950170-24-092714 001-35839 241183436 34 8568161 1 1
2024-08-05 8-K 8-K 2.02,9.01 0000950170-24-090722 001-35839 241174704 34 398879 1 1
2024-07-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-013820 12411
2024-07-11 144 xsl144X01/primary_doc.xml 0001968582-24-000616 001-35839 241112792 33 6691
2024-06-17 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-012734 5245
2024-06-17 144 xsl144X01/primary_doc.xml 0001968582-24-000529 001-35839 241048375 33 5459
2024-05-08 S-8 S-8 0001193125-24-134274 333-279217 24926856 33 157588
2024-05-08 10-Q 10-Q 0000950170-24-055581 001-35839 24925697 34 8114094 1 1
2024-05-06 8-K 8-K 2.02,9.01 0000950170-24-053532 001-35839 24917465 34 399895 1 1
2024-05-01 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-009175 5551
2024-05-01 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-009173 6147
2024-03-12 8-K 8-K 5.02,5.07,9.01 0000950170-24-029889 001-35839 24741959 34 349914 1 1
2024-03-08 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-006052 5343
2024-03-08 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-006050 5295
2024-03-08 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-006046 5360
2024-03-08 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-006042 5333
2024-03-08 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-006038 5345
2024-03-08 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-006036 5343
2024-02-27 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-004659 7828
2024-02-27 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001609251-24-000004 005-87373 24684628 34 10153
2024-02-26 UPLOAD filename1.pdf 0000000000-24-002105 001-35839 39594
2024-02-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-003237 6515
2024-02-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-003235 6535
2024-02-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-003233 7445
2024-02-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-003231 6532
2024-02-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-003229 6518
2024-02-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-003226 6529
2024-02-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-003223 6513
2024-02-14 SC 13G/A armistice-enta123123a1.htm 0001172661-24-001225 005-87373 24636112 34 90675
2024-02-14 CORRESP filename1.htm 0000950170-24-015084 181190
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-020838 005-87373 24628252 34 13015
2024-02-08 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-02-08 16:00:00 9999999995-24-000353 333-275723 24610968 33 1720
2024-02-08 10-Q 10-Q 0000950170-24-012796 001-35839 24609439 34 6156129 1 1
2024-02-07 8-K 8-K 2.02,9.01 0000950170-24-012186 001-35839 24604270 34 348578 1 1
2024-02-07 UPLOAD filename1.pdf 0000000000-24-001469 001-35839 44330
2024-02-06 CORRESP filename1.htm 0001193125-24-024852 25655
2024-01-26 ARS ARS 0001193125-24-016781 001-35839 24568512 34 1136580
2024-01-26 DEFA14A DEFA14A 0001193125-24-016774 001-35839 24568473 34 321012
2024-01-26 DEF 14A DEF 14A 0000950170-24-007956 001-35839 24568257 34 15165565 1 1
2024-01-26 SC 13G/A enta_13ga.htm 0000908834-24-000024 005-87373 24564448 34 427340
2024-01-24 SC 13G/A us29251m1062_012424.txt 0001086364-24-002756 005-87373 24557859 34 13440
2024-01-22 SC 13G/A Enanta_Ph_Inc.txt 0000093751-24-000057 005-87373 24547759 34 8404
2024-01-11 SC 13G ENTA_SC13G_2024.htm 0001273087-24-000009 005-87373 24529439 34 81623
2023-12-26 8-K 8-K 5.02 0001193125-23-303014 001-35839 231513383 34 138431 1 1
2023-12-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-022695 4862
2023-12-12 144 xsl144X01/primary_doc.xml 0001177648-23-000002 001-35839 231482073 33 4585
2023-12-06 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-022057 5428
2023-12-06 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-022055 5453
2023-12-06 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-022053 6368
2023-12-06 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-022051 5440
2023-12-06 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-022049 5431
2023-12-06 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-022047 5451
2023-12-06 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-022045 5425
2023-12-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-021991 4652
2023-12-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-021989 4677
2023-12-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-021987 5736
2023-12-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-021985 4679
2023-12-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-021983 4699
2023-12-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-021981 4673
2023-11-27 UPLOAD filename1.pdf 0000000000-23-012856 333-275723 40313
2023-11-22 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-021385 5397
2023-11-22 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-021384 5422
2023-11-22 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-021383 5420
2023-11-22 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-021382 5404
2023-11-22 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-021381 5399
2023-11-22 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-021380 5410
2023-11-22 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-021379 5396
2023-11-22 S-3 S-3 0001193125-23-282292 333-275723 231434008 33 696187
2023-11-22 10-K 10-K 0000950170-23-065884 001-35839 231433769 34 11615268 1 1
2023-11-22 POSASR POSASR 0001193125-23-282244 333-258632 231433545 33 19638
2023-11-20 8-K 8-K 2.02,9.01 0000950170-23-065087 001-35839 231422756 34 412384 1 1
2023-11-16 SC 13G ENTA_SC13G.htm 0001273087-23-000147 005-87373 231415052 34 82031
2023-10-06 SC 13G/A us29251m1062_100523.txt 0001306550-23-010049 005-87373 231313914 34 13544
2023-08-08 S-8 S-8 0001193125-23-206251 333-273800 231151757 33 63950
2023-08-08 10-Q 10-Q 0000950170-23-039754 001-35839 231151043 34 8726562 1 1
2023-08-07 8-K 8-K 2.02,9.01 0000950170-23-039051 001-35839 231147614 34 544178 1 1
2023-06-07 8-K 8-K 7.01,9.01 0000950170-23-026739 001-35839 23997627 34 16352059 1 1
2023-05-09 10-Q 10-Q 0000950170-23-019842 001-35839 23903242 34 7932233 1 1
2023-05-08 8-K 8-K 2.02,9.01 0000950170-23-018788 001-35839 23897733 34 532731 1 1
2023-04-27 8-K 8-K 1.01,7.01,9.01 0001193125-23-122434 001-35839 23857900 34 557761 1 1
2023-04-19 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-009374 7451
2023-03-17 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-007225 6412
2023-03-17 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-007223 10225
2023-03-17 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-007221 10463
2023-03-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-006867 12117
2023-03-10 8-K 8-K 7.01 0000950170-23-007317 001-35839 23724323 34 159831 1 1
2023-03-07 8-K 8-K 5.07,9.01 0000950170-23-006453 001-35839 23712469 34 452318 1 1
2023-03-06 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-006097 5235
2023-03-06 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-006095 5187
2023-03-06 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-006093 5252
2023-03-06 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-006091 5225
2023-03-06 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-006089 5237
2023-03-06 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-006087 5235
2023-02-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-003721 8479
2023-02-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-003719 8494
2023-02-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-003717 9462
2023-02-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-003715 8476
2023-02-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-003713 8482
2023-02-15 4/A AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-003712 8872
2023-02-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-003705 8480
2023-02-14 SC 13G/A firstmanhattan-enta123122a1.htm 0001172661-23-001232 005-87373 23627219 34 57350
2023-02-14 SC 13G armistice-enta123122.htm 0001172661-23-001089 005-87373 23625742 34 90562
2023-02-13 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-002936 6767
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-015863 005-87373 23603106 34 12934
2023-02-08 10-Q 10-Q 0000950170-23-002134 001-35839 23599095 34 7261679 1 1
2023-02-08 SC 13G/A Enanta_Pharmaceuticals_Inc.txt 0000093751-23-000364 005-87373 23598348 34 10279
2023-02-07 8-K 8-K 2.02,9.01 0000950170-23-001981 001-35839 23595088 34 475228 1 1
2023-02-07 ARS ARS 0001193125-23-026818 001-35839 23594643 34 8414361
2023-02-06 SC 13G/A AMENDMENT #4 0000908834-23-000024 005-87373 23588787 34 441782
2023-01-31 SC 13G us29251m1062_013123.txt 0001306550-23-005211 005-87373 23572263 34 13217
2023-01-20 DEFA14A DEFA14A 0001193125-23-011986 001-35839 23540972 34 326601
2023-01-20 DEF 14A DEF 14A 0001193125-23-011979 001-35839 23540959 34 1177666
2023-01-10 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-000800 6483
2022-12-19 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-024175 6484
2022-12-19 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-024173 6486
2022-12-16 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-024037 15859
2022-12-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-023369 4621
2022-12-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-023367 4636
2022-12-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-023365 5585
2022-12-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-023363 4639
2022-12-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-023361 4647
2022-12-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-023359 4642
2022-11-28 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-022861 7297
2022-11-28 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-022859 7312
2022-11-28 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-022857 8402
2022-11-28 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-022854 7314
2022-11-28 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-022846 7291
2022-11-28 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-022841 7299
2022-11-28 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-022837 7297
2022-11-23 10-K 10-K 0000950170-22-025667 001-35839 221416457 34 14802984 1 1
2022-11-21 8-K 8-K 2.02,9.01 0000950170-22-025532 001-35839 221405827 34 428030 1 1
2022-08-26 8-K 8-K 1.01,9.01 0001193125-22-231310 001-35839 221205289 34 425093 1 1
2022-08-26 424B5 424B5 0001193125-22-231299 333-258632 221205249 33 415645
2022-08-11 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-017745 7576
2022-08-11 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-017743 6141
2022-08-08 10-Q 10-Q 0000950170-22-015515 001-35839 221144385 34 9329218 1 1
2022-08-08 8-K 8-K 2.02,9.01 0000950170-22-015505 001-35839 221144283 34 537772 1 1
2022-06-22 8-K 8-K 8.01 0001193125-22-178106 001-35839 221029916 34 142667 1 1
2022-06-21 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-015258 6484
2022-05-17 8-K 8-K 1.01,9.01 0001193125-22-153071 001-35839 22935117 34 4096352 1 1
2022-05-09 S-8 S-8 0001193125-22-145016 333-264794 22905314 33 66849
2022-05-09 10-Q 10-Q 0000950170-22-008483 001-35839 22904942 34 8930394 1 1
2022-05-09 8-K 8-K 2.02,9.01 0000950170-22-008469 001-35839 22904769 34 518583 1 1
2022-04-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-009836 34728
2022-03-22 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-008344 13502
2022-03-09 8-K 8-K 5.02,9.01 0000950170-22-003221 001-35839 22725368 34 164454 1 1
2022-03-08 8-K 8-K 5.07,9.01 0000950170-22-003118 001-35839 22721628 34 415885 1 1
2022-03-07 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-007013 5232
2022-03-07 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-007011 5184
2022-03-07 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-007007 5249
2022-03-07 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-007005 5222
2022-03-07 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-007003 5234
2022-03-07 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-007001 5232
2022-03-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-006708 15085
2022-02-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-004522 8473
2022-02-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-004520 8488
2022-02-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-004518 9459
2022-02-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-004516 8493
2022-02-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-004514 8472
2022-02-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-004512 8478
2022-02-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-004510 8477
2022-02-15 SC 13G/A SC 13G/A 0001193125-22-042398 005-87373 22635922 34 69738
2022-02-15 SC 13G firstmanhattan-enta123121.htm 0001172661-22-000953 005-87373 22635689 34 56754
2022-02-14 SC 13G/A SC 13G/A 0001193125-22-042205 005-87373 22634754 34 64251
2022-02-11 SC 13G/A AMENDMENT #3 0000908834-22-000087 005-87373 22618892 34 394938
2022-02-11 SC 13G/A ENANTA_PHARMACEUTICALS_INC.txt 0000093751-22-000253 005-87373 22617782 34 8402
2022-02-10 SC 13G/A enta-13g_20211231.txt 0001037389-22-000038 005-87373 22615722 34 13294
2022-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-22-017459 005-87373 22609684 34 12929
2022-02-10 NT 10-Q NT 10-Q 0001193125-22-033095 001-35839 22609337 34 22290
2022-02-10 10-Q 10-Q 0000950170-22-001018 001-35839 22609057 34 7559496 1 1
2022-02-08 8-K 8-K 2.02,9.01 0000950170-22-000875 001-35839 22600463 34 422950 1 1
2022-02-04 SC 13G/A SC 13G/A 0001104659-22-011970 005-87373 22593300 34 46510
2022-01-28 SC 13G/A us29251m1062_012822.txt 0000834237-22-003234 005-87373 22567303 34 13225
2022-01-21 DEFA14A DEFA14A 0001564590-22-001955 001-35839 22545941 34 1064040
2022-01-21 DEF 14A DEF 14A 0001564590-22-001953 001-35839 22545917 34 4108570
2022-01-18 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-001104 6481
2022-01-13 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-001041 12034
2021-12-17 SC 13D/A SC 13D/A 0001193125-21-361165 005-87373 211502014 34 32390
2021-12-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-21-012216 5603
2021-12-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-21-012213 23543
2021-12-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-21-012201 4615
2021-12-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-21-012199 4623
2021-12-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-21-012197 4619
2021-11-24 10-K 10-K 0000950170-21-004895 001-35839 211446358 34 14317907 1 1
2021-11-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-21-011518 7431
2021-11-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-21-011516 7446
2021-11-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-21-011512 8581
2021-11-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-21-011509 7449
2021-11-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-21-011504 7426
2021-11-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-21-011500 7802
2021-11-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-21-011498 7433
2021-11-22 8-K 8-K 2.02,9.01 0000950170-21-004845 001-35839 211432531 34 495282 1 1
2021-11-02 4 PRIMARY DOCUMENT 0001177648-21-000029 12062
2021-10-13 4 PRIMARY DOCUMENT 0001177648-21-000027 13680
2021-09-17 4 PRIMARY DOCUMENT 0001177648-21-000025 5117
2021-08-23 4 PRIMARY DOCUMENT 0001177648-21-000023 5080
2021-08-23 3 PRIMARY DOCUMENT 0001177648-21-000021 6247
2021-08-23 8-K 8-K HATA DIRECTOR 5.02 0001564590-21-045408 001-35839 211196803 34 159054 1 1
2021-08-09 S-3ASR S-3ASR 0001564590-21-042633 333-258632 211156581 33 1028590
2021-08-09 10-Q Q3 2021 10-Q 0001564590-21-042612 001-35839 211156416 34 8389651 1 1
2021-08-05 8-K 8-K 2.02,9.01 0001564590-21-041571 001-35839 211148090 34 499305 1 1
2021-07-16 8-K 8-K NATHALIE ADDA RETIREMENT 5.02 0001564590-21-036895 001-35839 211095558 34 159457 1 1
2021-05-10 S-8 S-8 2021 0001564590-21-026049 333-255957 21907265 33 100090
2021-05-10 10-Q 10-Q 0001564590-21-026025 001-35839 21906962 34 8246431 1 1
2021-05-06 8-K 8-K Q2 2021 EARNINGS RELEASE 2.02,9.01 0001564590-21-024938 001-35839 21897630 34 505763 1 1
2021-03-05 8-K 8-K PROXY VOTE 5.02,5.07,9.01 0001564590-21-011253 001-35839 21718424 34 356691 1 1
2021-03-04 4 PRIMARY DOCUMENT 0001177648-21-000019 5348
2021-03-04 4 PRIMARY DOCUMENT 0001177648-21-000017 5300
2021-03-04 4 PRIMARY DOCUMENT 0001177648-21-000015 5365
2021-03-04 4 PRIMARY DOCUMENT 0001177648-21-000013 5350
2021-03-04 4 PRIMARY DOCUMENT 0001177648-21-000011 5340
2021-02-16 SC 13G d8805014_13g.htm 0000919574-21-001684 005-87373 21640594 34 94829
2021-02-16 SC 13G/A enta13gadec20.txt 0000080255-21-001201 005-87373 34 6975
2021-02-16 SC 13G/A AMENDMENT NO. 3 0001214659-21-001719 005-87373 21630860 34 291242
2021-02-10 SC 13G enta-13g_20201231.txt 0001037389-21-000018 005-87373 21612516 34 13289
2021-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-21-017985 005-87373 21610641 34 13804
2021-02-09 10-Q 10-Q 0001564590-21-004983 001-35839 21606396 34 7528768 1 1
2021-02-09 SC 13G Enanta_Pharmaceuticals_Inc.txt 0000093751-21-000136 005-87373 21604940 34 8438
2021-02-08 8-K 8-K 2.02,9.01 0001564590-21-004686 001-35839 21601434 34 452885 1 1
2021-02-05 8-K 8-K ABBVIE 8.01 OTHER EVENTS 8.01,9.01 0001564590-21-004518 001-35839 21596054 34 1954410 1 1
2021-01-28 4 PRIMARY DOCUMENT 0001177648-21-000008 13242
2021-01-28 DEFR14A DEFR14A 0001564590-21-003009 001-35839 21564916 34 2984463
2021-01-28 SC 13G/A SC 13G/A 0001104659-21-008449 005-87373 21562143 34 47642
2021-01-27 4 PRIMARY DOCUMENT 0001177648-21-000006 5551
2021-01-27 3 PRIMARY DOCUMENT 0001177648-21-000004 6416
2021-01-25 SC 13G us29251m1062_012521.txt 0000834237-21-000454 005-87373 21550202 34 13168
2021-01-21 DEF 14A 2022 ENANTA PHARMACEUTICALS PROXY 0001564590-21-001788 001-35839 21542297 34 2982407
2021-01-21 DEFA14A DEFA14A 0001564590-21-001776 001-35839 21542041 34 813228
2021-01-08 4 PRIMARY DOCUMENT 0001177648-21-000002 5117
2020-12-16 4 PRIMARY DOCUMENT 0001177648-20-000059 9632
2020-12-16 4 PRIMARY DOCUMENT 0001177648-20-000057 8910
2020-12-16 4 PRIMARY DOCUMENT 0001177648-20-000055 8694
2020-12-16 4 PRIMARY DOCUMENT 0001177648-20-000053 8684
2020-12-16 4 PRIMARY DOCUMENT 0001177648-20-000051 8679
2020-12-08 4 PRIMARY DOCUMENT 0001177648-20-000049 5567
2020-12-08 3 PRIMARY DOCUMENT 0001177648-20-000047 6499
2020-12-07 4 PRIMARY DOCUMENT 0001177648-20-000045 7440
2020-12-04 8-K 8-K 5.02 0001564590-20-056183 001-35839 201369885 34 158623 1 1
2020-11-25 10-K 10-K 0001564590-20-055233 001-35839 201350472 34 14090632 1 1
2020-11-23 8-K 8-K Q4 2020 2.02,9.01 0001564590-20-054888 001-35839 201337265 34 486652 1 1
2020-11-20 4 PRIMARY DOCUMENT 0001177648-20-000043 8392
2020-11-20 4 PRIMARY DOCUMENT 0001177648-20-000041 7472
2020-11-20 4 PRIMARY DOCUMENT 0001177648-20-000039 7449
2020-11-20 4 PRIMARY DOCUMENT 0001177648-20-000037 7457
2020-11-20 4 PRIMARY DOCUMENT 0001177648-20-000035 7452
2020-11-12 4 PRIMARY DOCUMENT 0001177648-20-000033 6505
2020-08-10 10-Q 10-Q 0001564590-20-038908 001-35839 201089365 34 9155971 1 1
2020-08-06 4 PRIMARY DOCUMENT 0001177648-20-000031 7793
2020-08-04 8-K 8-K 2.02,9.01 0001564590-20-036125 001-35839 201073519 34 509404 1 1
2020-07-01 4 PRIMARY DOCUMENT 0001177648-20-000029 5193
2020-07-01 3 PRIMARY DOCUMENT 0001177648-20-000027 6315
2020-06-30 8-K 8-K NEW DIRECTOR - MARK FOLETTA 5.02 0001564590-20-031261 001-35839 201002311 34 159824 1 1
2020-05-11 10-Q 10-Q 0001564590-20-024177 001-35839 20864827 34 8868517 1 1
2020-05-07 4 PRIMARY DOCUMENT 0001177648-20-000024 7038
2020-05-06 8-K 8-K Q2 2020 EARNINGS RELEASE 2.02,9.01 0001564590-20-021925 001-35839 20852677 34 496736 1 1
2020-03-16 4 PRIMARY DOCUMENT 0001177648-20-000022 8008
2020-03-04 SC 13D/A SC 13D/A 0001193125-20-061622 005-87373 20687219 34 32197
2020-03-02 8-K 8-K 2020 PROXY VOTE 5.07 0001564590-20-008143 001-35839 20676805 34 200469 1 1
2020-02-28 4 PRIMARY DOCUMENT 0001177648-20-000020 5331
2020-02-28 4 PRIMARY DOCUMENT 0001177648-20-000018 5283
2020-02-28 4 PRIMARY DOCUMENT 0001177648-20-000016 5348
2020-02-28 4 PRIMARY DOCUMENT 0001177648-20-000014 5323
2020-02-28 4 PRIMARY DOCUMENT 0001177648-20-000012 5331
2020-02-18 4 PRIMARY DOCUMENT 0001177648-20-000010 9747
2020-02-18 4 PRIMARY DOCUMENT 0001177648-20-000009 8796

Latest XBRL company facts

One latest value per concept from companyfacts (369 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 29.16M 2026-11-06 2026 FY 10-K 2026-11-18 0001193125-26-466170
dei EntityPublicFloat Entity Public Float USD 264.30M 2026-03-31 2026 FY 10-K 2026-11-18 0001193125-26-466170
ffd NetFeeAmt NetFeeAmt USD 3,287.89 2026-05-11 S-8 2026-05-13 0001193125-26-220600
ffd TtlFeeAmt TtlFeeAmt USD 3,287.89 2026-05-11 S-8 2026-05-13 0001193125-26-220600
ffd TtlOfferingAmt TtlOfferingAmt USD 23.81M 2026-05-11 S-8 2026-05-13 0001193125-26-220600
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-05-11 S-8 2026-05-13 0001193125-26-220600
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 2.75M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap AccountsPayableTradeCurrent Accounts Payable, Trade, Current USD 441,000 2016-09-30 2016 FY 10-K 2016-12-09 0001193125-16-789660
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 5.86M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 100,000 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 1.39M 2018-09-30 2019 FY 10-K 2019-11-27 0001564590-19-044729
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 14.69M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 950,000 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap AccruedRentNoncurrent Accrued Rent, Noncurrent USD 900,000 2019-09-30 2020 FY 10-K 2020-11-25 0001564590-20-055233
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 32.97M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 28.58M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -983,000 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 224.62M 2014-12-31 2015 Q1 10-Q 2015-02-06 0001193125-15-037392
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 554.06M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 14.03M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 4.59M 2012-10-01 2013-09-30 2015 FY 10-K 2015-12-11 0001193125-15-401602
us-gaap AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net USD 213,000 2016-10-01 2017-09-30 2019 FY 10-K 2019-11-27 0001564590-19-044729
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 14.03M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 0 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 4.80M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 5.56M 2021-10-01 2022-06-30 2022 Q3 10-Q 2022-08-08 0000950170-22-015515
us-gaap AssetRetirementObligationsNoncurrent Asset Retirement Obligations, Noncurrent USD 354,000 2022-06-30 2022 Q3 10-Q 2022-08-08 0000950170-22-015515
us-gaap Assets Assets USD 275.58M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap AssetsCurrent Assets, Current USD 205.99M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap AssetsFairValueAdjustment Assets, Fair Value Adjustment USD 0 2020-10-01 2021-09-30 2021 FY 10-K 2021-11-24 0000950170-21-004895
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 184.63M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 599,000 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 174.84M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedGain Debt Securities, Available-for-sale, Unrealized Gain USD 1,000 2017-10-01 2018-09-30 2018 FY 10-K 2018-11-29 0001564590-18-030275
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedLoss Debt Securities, Available-for-sale, Unrealized Loss USD 575,000 2017-10-01 2018-09-30 2018 FY 10-K 2018-11-29 0001564590-18-030275
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 221.98M 2018-03-31 2018 Q2 10-Q 2018-05-10 0001564590-18-012940
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 9,000 2017-09-30 2018 Q2 10-Q 2018-05-10 0001564590-18-012940
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 1.10M 2018-03-31 2018 Q2 10-Q 2018-05-10 0001564590-18-012940
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 223.08M 2018-03-31 2018 Q2 10-Q 2018-05-10 0001564590-18-012940
us-gaap AvailableForSaleSecuritiesCurrent Available-for-sale Securities, Current USD 230.75M 2018-06-30 2018 Q3 10-Q 2018-08-09 0001564590-18-021062
us-gaap AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value USD 23.57M 2014-12-31 2015 Q1 10-Q 2015-02-06 0001193125-15-037392
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 174.24M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 174.24M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 42.51M 2024-06-30 2024 Q3 10-Q 2024-08-07 0000950170-24-092714
us-gaap AvailableForSaleSecuritiesFairValueDisclosure Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) USD 47.28M 2013-03-31 2013 Q2 10-Q 2013-05-15 0001193125-13-220330
us-gaap AvailableforsaleSecuritiesGrossUnrealizedGain Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) USD 7,000 2013-03-31 2013 Q2 10-Q 2013-05-15 0001193125-13-220330
us-gaap AvailableForSaleSecuritiesGrossUnrealizedLosses1 Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) USD 14,000 2013-03-31 2013 Q2 10-Q 2013-05-15 0001193125-13-220330
us-gaap AvailableForSaleSecuritiesNoncurrent Available-for-sale Securities, Noncurrent USD 22.27M 2018-06-30 2018 Q3 10-Q 2018-08-09 0001564590-18-021062
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 39,000 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap CapitalLeaseObligations Capital Lease Obligations USD 598,000 2015-09-30 2015 FY 10-K 2015-12-11 0001193125-15-401602
us-gaap CapitalLeaseObligationsCurrent Capital Lease Obligations, Current USD 79,000 2017-09-30 2017 FY 10-K 2017-12-11 0001564590-17-024794
us-gaap CapitalLeaseObligationsIncurred Lease Obligation Incurred USD 598,000 2014-10-01 2015-09-30 2017 FY 10-K 2017-12-11 0001564590-17-024794
us-gaap CapitalLeaseObligationsNoncurrent Capital Lease Obligations, Noncurrent USD 200,000 2019-09-30 2020 FY 10-K 2020-11-25 0001564590-20-055233
us-gaap CapitalLeasesFutureMinimumPaymentsDue Capital Leases, Future Minimum Payments Due USD 293,000 2019-09-30 2020 Q3 10-Q 2020-08-10 0001564590-20-038908
us-gaap CapitalLeasesFutureMinimumPaymentsDueCurrent Capital Leases, Future Minimum Payments Due, Next Twelve Months USD 93,000 2019-09-30 2019 FY 10-K 2019-11-27 0001564590-19-044729
us-gaap CapitalLeasesFutureMinimumPaymentsDueInFiveYears Capital Leases, Future Minimum Payments Due in Five Years USD 99,000 2017-09-30 2017 FY 10-K 2017-12-11 0001564590-17-024794
us-gaap CapitalLeasesFutureMinimumPaymentsDueInFourYears Capital Leases, Future Minimum Payments Due in Four Years USD 99,000 2018-09-30 2018 FY 10-K 2018-11-29 0001564590-18-030275
us-gaap CapitalLeasesFutureMinimumPaymentsDueInThreeYears Capital Leases, Future Minimum Payments Due in Three Years USD 99,000 2019-09-30 2020 Q3 10-Q 2020-08-10 0001564590-20-038908
us-gaap CapitalLeasesFutureMinimumPaymentsDueInTwoYears Capital Leases, Future Minimum Payments Due in Two Years USD 101,000 2019-09-30 2020 Q3 10-Q 2020-08-10 0001564590-20-038908
us-gaap CapitalLeasesFutureMinimumPaymentsDueThereafter Capital Leases, Future Minimum Payments Due Thereafter USD 99,000 2016-09-30 2016 FY 10-K 2016-12-09 0001193125-16-789660
us-gaap CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear Capital Leases, Future Minimum Payments, Remainder of Fiscal Year USD 93,000 2019-09-30 2020 Q3 10-Q 2020-08-10 0001564590-20-038908
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 20.27M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 12.88M 2017-03-31 2017 Q2 10-Q 2017-05-10 0001564590-17-010224
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -1.77M 2017-10-01 2018-09-30 2018 FY 10-K 2018-11-29 0001564590-18-030275
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 194.51M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 23.63M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -12.03M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) USD/Warrant 0.01 2013-09-30 2013 FY 10-K 2013-12-18 0001193125-13-477878
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 0 2018-09-30 2018 FY 10-K 2018-11-29 0001564590-18-030275
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 185,614 2015-09-30 2015 FY 10-K 2015-12-11 0001193125-15-401602
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 100.00M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 29.14M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 29.14M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap CommonStockValue Common Stock, Value, Issued USD 291,000 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -68.89M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 161.81M 2012-10-01 2013-09-30 2015 FY 10-K 2015-12-11 0001193125-15-401602
us-gaap CostsAndExpenses Costs and Expenses USD 125.38M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap CurrentFederalStateAndLocalTaxExpenseBenefit Current Federal, State and Local, Tax Expense (Benefit) USD 200.00M 2023-04-01 2023-04-30 2024 Q3 10-Q 2024-08-07 0000950170-24-092714
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 40,000 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 2.00M 2010-11-30 2013 FY 10-K 2013-12-18 0001193125-13-477878
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 6.50M 2010-10-31 2013 FY 10-K 2013-12-18 0001193125-13-477878
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.05 2010-10-31 2013 FY 10-K 2013-12-18 0001193125-13-477878
us-gaap DebtInstrumentUnusedBorrowingCapacityAmount Debt Instrument, Unused Borrowing Capacity, Amount USD 4.50M 2010-11-30 2013 FY 10-K 2013-12-18 0001193125-13-477878
us-gaap DebtIssuanceCosts Debt Issuance Cost (Deprecated 2016-01-31) USD 41,000 2010-10-01 2011-09-30 2013 FY 10-K 2013-12-18 0001193125-13-477878
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded USD 0 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 2.13M 2012-09-30 2013 FY 10-K 2013-12-18 0001193125-13-477878
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 345,000 2020-09-30 2021 FY 10-K 2021-11-24 0000950170-21-004895
us-gaap DeferredIncomeTaxesAndTaxCredits Deferred Income Taxes and Tax Credits USD 0 2022-10-01 2023-09-30 2023 FY 10-K 2023-11-22 0000950170-23-065884
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -18.26M 2019-10-01 2020-09-30 2021 FY 10-K 2021-11-24 0000950170-21-004895
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 10.82M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 10,000 2013-09-30 2014 FY 10-K 2014-12-11 0001193125-14-440235
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 7.56M 2014-06-30 2014 FY 10-K 2014-12-11 0001193125-14-440235
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 170.32M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 47.92M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap DeferredTaxAssetsLiabilitiesNetCurrent Deferred Tax Assets, Net, Current USD 1.45M 2015-09-30 2016 FY 10-K 2016-12-09 0001193125-16-789660
us-gaap DeferredTaxAssetsLiabilitiesNetNoncurrent Deferred Tax Assets, Net, Noncurrent USD 12.42M 2020-03-31 2020 Q2 10-Q 2020-05-11 0001564590-20-024177
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 10.82M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 43.97M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 124,000 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap DeferredTaxAssetsOtherComprehensiveLoss Deferred Tax Assets, Other Comprehensive Loss USD 139,000 2018-09-30 2019 FY 10-K 2019-11-27 0001564590-19-044729
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 28.12M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation USD 925,000 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 12.11M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 114,000 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap DeferredTaxAssetsUnrealizedLossesOnTradingSecurities Deferred Tax Assets, Unrealized Losses on Trading Securities USD 0 2024-09-30 2024 FY 10-K 2024-11-27 0000950170-24-131260
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 159.50M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap DeferredTaxExpenseFromStockOptionsExercised Deferred Tax Expense from Stock Options Exercised USD -105,000 2013-10-01 2014-06-30 2014 Q3 10-Q 2014-08-12 0001193125-14-305189
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 7.40M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap DeferredTaxLiabilitiesOtherComprehensiveIncome Deferred Tax Liabilities, Other Comprehensive Income USD 9,000 2025-09-30 2025 FY 10-K 2025-11-19 0001193125-25-288121
us-gaap DeferredTaxLiabilitiesPrepaidExpenses Deferred Tax Liabilities, Prepaid Expenses USD 152,000 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 3.39M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 1.57M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.02 2012-10-01 2013-09-30 2013 FY 10-K 2013-12-18 0001193125-13-477878
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount Defined Contribution Plan, Maximum Annual Contributions Per Employee, Amount USD 8,000 2013-10-01 2014-09-30 2015 FY 10-K 2015-12-11 0001193125-15-401602
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 4.78M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap DerivativeFairValueOfDerivativeLiability Derivative Liability, Fair Value, Gross Liability USD 1.68M 2014-06-30 2014 Q3 10-Q 2014-08-12 0001193125-14-305189
us-gaap DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net USD -27,000 2020-10-01 2021-09-30 2021 FY 10-K 2021-11-24 0000950170-21-004895
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 1.43M 2014-12-31 2015 Q1 10-Q 2015-02-06 0001193125-15-037392
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.35 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.35 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.001 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.234 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0.003 2014-10-01 2015-09-30 2017 FY 10-K 2017-12-11 0001564590-17-024794
us-gaap EffectiveIncomeTaxRateReconciliationFdiiPercent EffectiveIncomeTaxRateReconciliationFdiiPercent pure 0 2024-10-01 2025-09-30 2025 FY 10-K 2025-11-19 0001193125-25-288121
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0.001 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure -0.015 2024-10-01 2025-09-30 2025 FY 10-K 2025-11-19 0001193125-25-288121
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0.017 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.004 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingenciesOther Effective Income Tax Rate Reconciliation, Tax Contingency, Other, Percent pure 0.5 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.045 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act, Percent pure 0.35 2020-10-01 2021-09-30 2021 FY 10-K 2021-11-24 0000950170-21-004895
us-gaap EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability Embedded Derivative, Fair Value of Embedded Derivative Liability USD 670,000 2013-09-30 2013 FY 10-K 2013-12-18 0001193125-13-477878
us-gaap EmbeddedDerivativeGainOnEmbeddedDerivative Embedded Derivative, Gain on Embedded Derivative USD 670,000 2010-10-01 2011-09-30 2013 FY 10-K 2013-12-18 0001193125-13-477878
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 7.37M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 14.83M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ExcessTaxBenefitFromShareBasedCompensationFinancingActivities Excess Tax Benefit from Share-based Compensation, Financing Activities USD 213,000 2016-10-01 2017-09-30 2019 FY 10-K 2019-11-27 0001564590-19-044729
us-gaap ExcessTaxBenefitFromShareBasedCompensationOperatingActivities Excess Tax Benefit from Share-based Compensation, Operating Activities USD 213,000 2016-10-01 2017-09-30 2019 FY 10-K 2019-11-27 0001564590-19-044729
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) USD -60,000 2015-10-01 2016-03-31 2016 Q2 10-Q 2016-05-10 0001193125-16-585576
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 1.38M 2016-03-31 2016 Q2 10-Q 2016-05-10 0001193125-16-585576
us-gaap FederalIncomeTaxExpenseBenefitContinuingOperations Federal Income Tax Expense (Benefit), Continuing Operations USD 28.72M 2020-10-01 2021-09-30 2021 FY 10-K 2021-11-24 0000950170-21-004895
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 31,000 2014-10-01 2015-09-30 2015 FY 10-K 2015-12-11 0001193125-15-401602
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 0 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap GainLossOnDispositionOfProperty Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) USD 55,000 2011-10-01 2012-03-31 2013 Q2 10-Q 2013-05-15 0001193125-13-220330
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 21,000 2014-10-01 2015-06-30 2015 Q3 10-Q 2015-08-10 0001193125-15-284854
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 36.84M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD 9.63M 2012-10-01 2013-09-30 2013 FY 10-K 2013-12-18 0001193125-13-477878
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -68.21M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap IncomeTaxCreditsAndAdjustments Income Tax Credits and Adjustments USD -750,000 2010-10-01 2011-09-30 2013 FY 10-K 2013-12-18 0001193125-13-477878
us-gaap IncomeTaxesPaid Income Taxes Paid USD 0 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 12.62M 2015-10-01 2016-09-30 2016 FY 10-K 2016-12-09 0001193125-16-789660
us-gaap IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority USD 871,000 2019-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 40,000 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability USD -9.28M 2014-10-01 2015-06-30 2015 Q3 10-Q 2015-08-10 0001193125-15-284854
us-gaap IncomeTaxReceivable Income Taxes Receivable USD 19,000 2026-03-31 2026 Q2 10-Q 2026-05-13 0001193125-26-220572
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -15.94M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -14.32M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD -46,000 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD -1.17M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -5,000 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -262,000 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD -12,000 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 3.07M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 763,000 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -1.03M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap IncreaseDecreaseInAccruedIncomeTaxesPayable Increase (Decrease) in Income Taxes Payable USD -1.39M 2018-10-01 2019-09-30 2021 FY 10-K 2021-11-24 0000950170-21-004895
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 1.93M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -10,000 2013-10-01 2014-09-30 2015 FY 10-K 2015-12-11 0001193125-15-401602
us-gaap IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) USD 234,000 2012-10-01 2013-03-31 2013 Q2 10-Q 2013-05-15 0001193125-13-220330
us-gaap IncreaseDecreaseInIncomeTaxesReceivable Increase (Decrease) in Income Taxes Receivable USD 0 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -3.15M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 24,000 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 35,000 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -22,000 2012-10-01 2013-09-30 2015 FY 10-K 2015-12-11 0001193125-15-401602
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -2.96M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 172,000 2014-10-01 2015-06-30 2016 Q3 10-Q 2016-08-09 0001193125-16-676744
us-gaap IncreaseDecreaseInUnbilledReceivables Increase (Decrease) in Unbilled Receivables USD -433,000 2015-10-01 2016-09-30 2018 FY 10-K 2018-11-29 0001564590-18-030275
us-gaap InterestExpense Interest Expense USD 8.36M 2023-10-01 2024-06-30 2024 Q3 10-Q 2024-08-07 0000950170-24-092714
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 14.07M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 11.59M 2023-10-01 2024-06-30 2024 Q3 10-Q 2024-08-07 0000950170-24-092714
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 20,000 2010-12-01 2010-12-31 2013 FY 10-K 2013-12-18 0001193125-13-477878
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 12.92M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap InterestReceivable Interest Receivable USD 3.29M 2024-09-30 2025 FY 10-K 2025-11-19 0001193125-25-288121
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 928,000 2017-10-01 2017-12-31 2018 Q1 10-Q 2018-02-09 0001564590-18-001764
us-gaap InvestmentIncomeNet Investment Income, Net USD 8.22M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap InvestmentsFairValueDisclosure Investments, Fair Value Disclosure USD 47.28M 2013-03-31 2013 Q2 10-Q 2013-05-15 0001193125-13-220330
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 2.49M 2018-10-01 2019-09-30 2019 FY 10-K 2019-11-27 0001564590-19-044729
us-gaap LeaseCost Lease, Cost USD 11.28M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 77.55M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 31.25M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 8.72M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 9.82M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 9.53M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 9.25M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 8.98M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 2.17M 2025-06-30 2025 Q3 10-Q 2025-08-13 0001193125-25-179795
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 22.79M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap LettersOfCreditOutstandingAmount Letters of Credit Outstanding, Amount USD 608,000 2021-09-30 2021 FY 10-K 2021-11-24 0000950170-21-004895
us-gaap Liabilities Liabilities USD 195.38M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 275.58M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap LiabilitiesCurrent Liabilities, Current USD 54.46M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 1.29M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap LiabilityForUncertainTaxPositionsNoncurrent Liability for Uncertainty in Income Taxes, Noncurrent USD 87,000 2022-06-30 2022 Q3 10-Q 2022-08-08 0000950170-22-015515
us-gaap LicenseCosts License Costs (Deprecated 2018-01-31) USD 200,000 2014-10-01 2015-09-30 2015 FY 10-K 2015-12-11 0001193125-15-401602
us-gaap MaintenanceCosts Maintenance Costs (Deprecated 2018-01-31) USD 105,000 2015-10-01 2016-06-30 2016 Q3 10-Q 2016-08-09 0001193125-16-676744
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 193.68M 2016-06-30 2016 Q3 10-Q 2016-08-09 0001193125-16-676744
us-gaap MarketableSecuritiesGainLoss Marketable Securities, Gain (Loss) USD 4,000 2014-10-01 2015-06-30 2016 Q3 10-Q 2016-08-09 0001193125-16-676744
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 21.99M 2026-06-30 2026 Q3 10-Q 2026-08-12 0001193125-26-345719
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 47.72M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 411,000 2017-10-01 2018-03-31 2018 Q2 10-Q 2018-05-10 0001564590-18-012940
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -17.18M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 4.01M 2017-10-01 2018-03-31 2018 Q2 10-Q 2018-05-10 0001564590-18-012940
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -42.56M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -3.17M 2017-10-01 2018-03-31 2018 Q2 10-Q 2018-05-10 0001564590-18-012940
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -68.25M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD 78.99M 2014-10-01 2015-09-30 2015 FY 10-K 2015-12-11 0001193125-15-401602
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD 78.99M 2014-10-01 2015-09-30 2015 FY 10-K 2015-12-11 0001193125-15-401602
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -5.83M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 21.63M 2017-07-01 2017-09-30 2017 FY 10-K 2017-12-11 0001564590-17-024794
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -62.38M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap OperatingLeaseCost Operating Lease, Cost USD 7.14M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 54.76M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 4.06M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 50.70M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap OperatingLeasePayments Operating Lease, Payments USD 8.47M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 35.25M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 9.34M 2019-09-30 2020 FY 10-K 2020-11-25 0001564590-20-055233
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 2.73M 2019-09-30 2020 FY 10-K 2020-11-25 0001564590-20-055233
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 519,000 2019-09-30 2020 FY 10-K 2020-11-25 0001564590-20-055233
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 608,000 2019-09-30 2020 FY 10-K 2020-11-25 0001564590-20-055233
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 2.68M 2019-09-30 2020 FY 10-K 2020-11-25 0001564590-20-055233
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 2.80M 2019-09-30 2020 FY 10-K 2020-11-25 0001564590-20-055233
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 519,000 2018-09-30 2018 FY 10-K 2018-11-29 0001564590-18-030275
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 2.73M 2019-09-30 2020 Q3 10-Q 2020-08-10 0001564590-20-038908
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.088 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 228,000 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 116,000 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -286,000 2017-10-01 2018-09-30 2018 FY 10-K 2018-11-29 0001564590-18-030275
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -644,000 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -644,000 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax USD 0 2021-10-01 2022-09-30 2022 FY 10-K 2022-11-23 0000950170-22-025667
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 295,000 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 0 2022-10-01 2023-09-30 2023 FY 10-K 2023-11-22 0000950170-23-065884
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 942,000 2021-10-01 2022-06-30 2022 Q3 10-Q 2022-08-08 0000950170-22-015515
us-gaap OtherSalesRevenueNet Other Revenue, Net (Deprecated 2018-01-31) USD 576,000 2015-10-01 2016-06-30 2017 Q3 10-Q 2017-08-09 0001564590-17-016945
us-gaap OtherSignificantNoncashTransactionValueOfConsiderationGiven1 Other Significant Noncash Transaction, Value of Consideration Given USD 1.08M 2011-10-01 2012-09-30 2014 FY 10-K 2014-12-11 0001193125-14-440235
us-gaap OtherSundryLiabilitiesCurrent Other Sundry Liabilities, Current USD 247,000 2014-06-30 2014 Q3 10-Q 2014-08-12 0001193125-14-305189
us-gaap OtherSundryLiabilitiesNoncurrent Other Sundry Liabilities, Noncurrent USD 190,000 2014-06-30 2014 Q3 10-Q 2014-08-12 0001193125-14-305189
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 6,000 2014-10-01 2015-06-30 2016 Q3 10-Q 2016-08-09 0001193125-16-676744
us-gaap PaymentsForProceedsFromOtherInvestingActivities Payments for (Proceeds from) Other Investing Activities USD 163,000 2014-10-01 2015-09-30 2017 FY 10-K 2017-12-11 0001564590-17-024794
us-gaap PaymentsForProceedsFromTenantAllowance Payments for (Proceeds from) Tenant Allowance USD -330,000 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 0 2024-10-01 2025-09-30 2025 FY 10-K 2025-11-19 0001193125-25-288121
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 3.54M 2012-10-01 2013-09-30 2015 FY 10-K 2015-12-11 0001193125-15-401602
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 423,000 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 231.88M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 206,000 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap PreferredStockLiquidationPreference Preferred Stock, Liquidation Preference Per Share USD/shares 1 2013-06-30 2013 Q3 10-Q 2013-08-12 0001193125-13-331068
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap PreferredStockShareSubscriptions Preferred Stock, Shares Subscribed but Unissued shares 3.00M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 5.63M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 2.00M 2010-10-01 2011-09-30 2013 FY 10-K 2013-12-18 0001193125-13-477878
us-gaap ProceedsFromIncomeTaxRefundFederal ProceedsFromIncomeTaxRefundFederal USD 0 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ProceedsFromIncomeTaxRefunds Proceeds from Income Tax Refunds USD 0 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-12 0001193125-26-345719
us-gaap ProceedsFromIncomeTaxRefundStateAndLocal ProceedsFromIncomeTaxRefundStateAndLocal USD 8,000 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 69.95M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 3.61M 2020-10-01 2021-09-30 2021 FY 10-K 2021-11-24 0000950170-21-004895
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 239.29M 2016-10-01 2017-09-30 2017 FY 10-K 2017-12-11 0001564590-17-024794
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 214.90M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ProceedsFromSaleOfAvailableForSaleSecurities Proceeds from Sale of Available-for-sale Securities USD 10.02M 2016-10-01 2017-09-30 2017 FY 10-K 2017-12-11 0001564590-17-024794
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 9,000 2014-10-01 2015-09-30 2015 FY 10-K 2015-12-11 0001193125-15-401602
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 819,000 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -68.25M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap PropertyPlantAndEquipmentDisposals Property, Plant and Equipment, Disposals USD 518,000 2014-10-01 2015-09-30 2015 FY 10-K 2015-12-11 0001193125-15-401602
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 59.44M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 30.86M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap RecordedUnconditionalPurchaseObligation Recorded Unconditional Purchase Obligation USD 437,000 2014-06-30 2014 Q3 10-Q 2014-08-12 0001193125-14-305189
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 2.00M 2010-10-01 2011-09-30 2013 FY 10-K 2013-12-18 0001193125-13-477878
us-gaap RepaymentsOfLongTermCapitalLeaseObligations Repayments of Long-term Capital Lease Obligations USD 86,000 2018-10-01 2019-09-30 2021 FY 10-K 2021-11-24 0000950170-21-004895
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 88.55M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 436,000 2013-09-30 2013 FY 10-K 2013-12-18 0001193125-13-477878
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 3.97M 2024-03-31 2024 Q2 10-Q 2024-05-08 0000950170-24-055581
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 0 2025-09-30 2025 FY 10-K 2025-11-19 0001193125-25-288121
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 3.36M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap RestrictedStockValueSharesIssuedNetOfTaxWithholdings Restricted Stock, Value, Shares Issued Net of Tax Withholdings USD -423,000 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -473.18M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 63.00M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap RevenueFromGrants Revenue from Grants (Deprecated 2018-01-31) USD 576,000 2015-10-01 2016-09-30 2017 FY 10-K 2017-12-11 0001564590-17-024794
us-gaap RevenueRecognitionMilestoneMethodRevenueRecognized Revenue Recognition, Milestone Method, Revenue Recognized USD 15.00M 2017-10-01 2018-03-31 2018 Q2 10-Q 2018-05-10 0001564590-18-012940
us-gaap Revenues Revenues USD 82.16M 2017-10-01 2018-03-31 2018 Q2 10-Q 2018-05-10 0001564590-18-012940
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap RoyaltyRevenue Royalty Revenue (Deprecated 2018-01-31) USD 67.16M 2017-10-01 2018-03-31 2018 Q2 10-Q 2018-05-10 0001564590-18-012940
us-gaap SecurityDeposit Security Deposit USD 92,000 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 14.03M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 0 2013-10-01 2014-09-30 2016 FY 10-K 2016-12-09 0001193125-16-789660
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.64 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.037 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 1.09M 2021-09-30 2021 FY 10-K 2021-11-24 0000950170-21-004895
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 4.82M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 4.52M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 40.2 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 471,000 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 456,000 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 233,000 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 401,280 2015-10-01 2015-12-31 2016 Q1 10-Q 2016-02-09 0001193125-16-455395
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.29M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 31.84 2017-10-01 2018-09-30 2018 FY 10-K 2018-11-29 0001564590-18-030275
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 8.56 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 8.00M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 6.27M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 32.37 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 8.00M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 6.27M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 32.37 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period shares 0 2015-09-29 2015-09-30 2015 FY 10-K 2015-12-11 0001193125-15-401602
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 8.96 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 43.85 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 12.84 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 13.72 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap SharePrice Share Price USD/shares 14 2013-03-26 2014 FY 10-K 2014-12-11 0001193125-14-440235
us-gaap SharesIssued Shares, Issued shares 20.72M 2022-06-30 2023 Q3 10-Q 2023-08-08 0000950170-23-039754
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 14 2013-03-26 2016 FY 10-K 2016-12-09 0001193125-16-789660
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 0 2021-10-01 2022-09-30 2022 FY 10-K 2022-11-23 0000950170-22-025667
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 80.19M 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap StockholdersEquityNoteStockSplitConversionRatio Stockholders' Equity Note, Stock Split, Conversion Ratio (Deprecated 2013-01-31) pure 0.232 2013-02-01 2013-03-01 2013 Q2 10-Q 2013-05-15 0001193125-13-220330
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 4.31 2013-03-01 2015 FY 10-K 2015-12-11 0001193125-15-401602
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 4.60M 2013-03-26 2016 FY 10-K 2016-12-09 0001193125-16-789660
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited Stock Issued During Period, Shares, Restricted Stock Award, Forfeited shares 208,816 2010-10-01 2011-09-30 2013 FY 10-K 2013-12-18 0001193125-13-477878
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 91,000 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 161.81M 2012-10-01 2013-09-30 2015 FY 10-K 2015-12-11 0001193125-15-401602
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 69.95M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 11.84M 2020-10-01 2021-09-30 2021 FY 10-K 2021-11-24 0000950170-21-004895
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 819,000 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap TemporaryEquityAccretionToRedemptionValue Temporary Equity, Accretion to Redemption Value USD -2.53M 2012-10-01 2013-09-30 2015 FY 10-K 2015-12-11 0001193125-15-401602
us-gaap TemporaryEquityAccretionToRedemptionValueAdjustment Temporary Equity, Accretion to Redemption Value, Adjustment USD 2.53M 2012-10-01 2013-09-30 2015 FY 10-K 2015-12-11 0001193125-15-401602
us-gaap TreasuryStockShares Treasury Stock, Shares shares 0 2015-09-30 2015 FY 10-K 2015-12-11 0001193125-15-401602
us-gaap TreasuryStockSharesRetired Treasury Stock, Shares, Retired shares 209,000 2014-10-01 2015-09-30 2017 FY 10-K 2017-12-11 0001564590-17-024794
us-gaap TreasuryStockValue Treasury Stock, Value USD 2,000 2014-09-30 2015 FY 10-K 2015-12-11 0001193125-15-401602
us-gaap UnbilledReceivablesCurrent Unbilled Receivables, Current USD 433,000 2015-09-30 2016 FY 10-K 2016-12-09 0001193125-16-789660
us-gaap UndistributedEarningsAllocatedToParticipatingSecurities Undistributed Earnings Allocated to Participating Securities (Deprecated 2014-01-31) USD 13.67M 2012-10-01 2013-06-30 2014 Q3 10-Q 2014-08-12 0001193125-14-305189
us-gaap UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic Undistributed Earnings (Loss) Allocated to Participating Securities, Basic USD 13.67M 2012-10-01 2013-09-30 2015 FY 10-K 2015-12-11 0001193125-15-401602
us-gaap UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted USD 13.67M 2012-10-01 2013-09-30 2015 FY 10-K 2015-12-11 0001193125-15-401602
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 882,000 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 39,000 2021-10-01 2022-09-30 2022 FY 10-K 2022-11-23 0000950170-22-025667
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 41,000 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 0 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 355,000 2016-10-01 2017-09-30 2018 FY 10-K 2018-11-29 0001564590-18-030275
us-gaap UnrecognizedTaxBenefitsPeriodIncreaseDecrease Unrecognized Tax Benefits, Period Increase (Decrease) USD 539,000 2019-10-01 2020-06-30 2020 Q3 10-Q 2020-08-10 0001564590-20-038908
us-gaap UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations USD 10,000 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD -17.27M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap VariableLeaseCost Variable Lease, Cost USD 4.14M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 807,000 2017-09-30 2018 FY 10-K 2018-11-29 0001564590-18-030275
us-gaap WarrantsNotSettleableInCashFairValueDisclosure Warrants Not Settleable in Cash, Fair Value Disclosure USD 1.28M 2010-12-31 2013 FY 10-K 2013-12-18 0001193125-13-477878
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 1.38M 2018-10-01 2019-09-30 2021 FY 10-K 2021-11-24 0000950170-21-004895
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 29.00M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 29.00M 2025-10-01 2026-09-30 2026 FY 10-K 2026-11-18 0001193125-26-466170
us-gaap WriteOffOfDeferredDebtIssuanceCost Write off of Deferred Debt Issuance Cost USD 150,000 2010-12-01 2010-12-31 2013 FY 10-K 2013-12-18 0001193125-13-477878

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →